Earl Howe (Con)

My Lords, this group of amendments in the name of my noble friend Lord Udny-Lister raises a number of sensible points about proportionality, transparency and evidence within the regulatory framework that the Bill will establish. Amendments 148A and 148C speak to the question of clarity and accountability, both in research and in representation. They would ensure that everyone—manufacturers, the Government and members of the public—can have sight of who exactly is responsible for carrying out studies on products and who is representing a manufacturer’s interests. I listened to what the noble Baroness, Lady Northover, said about a closed list. It seems to me that the besetting problem in this entire area is that the general public do not know what information they can rely on. There is an awful lot of myth and misinformation out there, as well as suspicion. By requiring that studies are undertaken by approved providers and that the nominated responsible person has a genuine connection to the UK, these amendments would bring about welcome transparency and help to provide confidence—to consumers and the industry alike—that those undertaking research and providing information are properly qualified and within reach of UK oversight. That principle seems very sensible. I would appreciate hearing the Minister’s thoughts on it.